ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,021Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 32

$737K Total Retail Price of All Prescriptions

Rank: 3 out of 32

552 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 7,193 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 415 292 1 2
HYDROCODONE-ACETAMINOPHEN 353 189 S3 2 1
METFORMIN HCL 294 193 3 9
LISINOPRIL 292 195 4 3
SIMVASTATIN 255 198 5 6
PRAVASTATIN SODIUM 228 168 6 10
OMEPRAZOLE 224 114 7 8
FUROSEMIDE 196 126 8 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 123 9 19
LEVOTHYROXINE SODIUM 170 126 10 4
ATORVASTATIN CALCIUM 164 97 11 15
METOPROLOL TARTRATE 152 101 12 7
CRESTOR 146 118 13 21
HYDROCHLOROTHIAZIDE 140 106 14 11
FLUTICASONE PROPIONATE 135 65 15 58
FAMOTIDINE 125 90 16 47
LOSARTAN POTASSIUM 123 87 17 37
JANUVIA 121 78 18 79
GABAPENTIN 119 76 19 16
AMLODIPINE BESYLATE-BENAZEPRIL 118 75 20 55
EXFORGE 113 72 21 131
LOSARTAN-HYDROCHLOROTHIAZIDE 110 77 22 45
VENTOLIN HFA 102 60 23 65
RANITIDINE HCL 101 74 24 12
NIFEDIPINE ER 99 92 25 99
TAMSULOSIN HCL 97 80 26 34
SINGULAIR 97 47 26 141
CLOPIDOGREL 94 60 28 38
WARFARIN SODIUM 90 53 29 25
CLONIDINE HCL 87 63 30 31
LYRICA 87 37 30 68
ACTOS 86 57 32 67
AMITRIPTYLINE HCL 86 56 R 32 90
DIOVAN HCT 86 62 32 61
POTASSIUM CHLORIDE 85 61 35 14
MELOXICAM 81 62 36 33
METFORMIN HCL ER 81 62 36 36
SPIRIVA 80 63 38 107
PROAIR HFA 80 48 38 77
ADVAIR DISKUS 79 36 40 124
ZOLPIDEM TARTRATE 78 37 41 20
CARVEDILOL 77 65 42 28
NEXIUM 76 49 43 23
ISOSORBIDE MONONITRATE ER 75 69 44 49
RISPERIDONE 74 21 45 39
TRAMADOL HCL 68 40 46 13
CYCLOBENZAPRINE HCL 66 39 R 47 100
DIOVAN 65 47 48 42
ATENOLOL 65 51 48 17
PLAVIX 64 54 50 64
COLCRYS 61 32 51 73
KLOR-CON M20 61 37 51 54
MIRTAZAPINE 59 39 53 50
HYDRALAZINE HCL 58 52 54 107
DOXAZOSIN MESYLATE 57 50 55 80
MONTELUKAST SODIUM 56 30 56 177
CYMBALTA 55 34 57 44
BYSTOLIC 55 33 57 180
ZETIA 55 33 57 91
ALLOPURINOL 54 38 60 26
INSULIN SYRINGE 51 33 61 75
PREDNISONE 50 39 62 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.